CEO Thibaut Mongon says Kenvue’s results for current quarter will be affected by “lingering impact of the distribution disruption we saw in China,” which “will take a little bit of time to fix.” Also, activist investor Starboard wants to bring “significant changes” to the board at firm’s annual shareholder meeting later in year.
Kenvue Inc.’s latest results show a moving target in the section of its business needing attention to spur sales growth as sales of the Listerine line and other essential health products dropped 4.1% in the fourth quarter while skin health and beauty product sales recovered to show slight growth.
Another target emerging for Kenvue management’s attention is Starboard Value and Opportunity Master Fund Ltd., owners of more than 22m...
Creating a working group to drive Rx-to-OTC switch is one of the ways in which Finland could expand self-care and save €60m per year for the country's health system, suggests a recently published report commissioned by Haleon.
Terclara - Moberg’s proprietary topical formulation of terbinafine for fungal nail - has established itself as the market leader in Norway just months after its OTC launch. The firm is now plotting its expansion to additional EU markets.
Reacting to chancellor Rachel Reeves' 2025 public spending review, PAGB welcomed increased funding for healthcare and life sciences while stressing the need to promote self-care practices.
